高级检索
当前位置: 首页 > 详情页

Genetic variants and mutational spectrum of Chinese Hermansky-Pudlak syndrome patients.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Dermatology, Beijing Tongren Hospital, Capital Medical University, Beijing, China [2]Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China [3]Genetics and Birth Defects Control Center, National Center for Children's Health, Beijing, China [4]MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China [5]Department of Ophthalmology, National Center for Children's Health, Beijing Children’s Hospital, Capital Medical University, Beijing, China [6]Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
出处:
ISSN:

关键词: albinism genetic variant genotyping Hermansky–Pudlak syndrome pathogenicity

摘要:
Hermansky-Pudlak syndrome (HPS) is a rare recessive disorder characterized by oculocutaneous albinism or ocular albinism, bleeding diathesis, and other symptoms such as colitis and pulmonary fibrosis. Eleven causative genes have been identified for HPS-1-HPS-11 subtypes in humans. We have identified 16 newly reported patients including the first HPS-2 case in the Chinese population. In a total of 40 HPS patients, hypopigmentation was milder in HPS-3, HPS-5, and HPS-6 patients than in HPS-1 and HPS-4 patients. HPS-1 accounted for 47.5% (19 of 40) of HPS cases which is the most common subtype. Exons 11 and 19 were the hotspots of the HPS1 gene mutations. In total, 55 allelic variants were identified in HPS1-HPS6 gene, of which 17 variants were previously unreported. These results will be useful for the evaluation of the relationship between HPS genotypes and phenotypes, and for the precise intervention of HPS patients in the Chinese population. © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 皮肤病学 3 区 细胞生物学 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 2 区 皮肤病学 3 区 细胞生物学 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q1 DERMATOLOGY Q2 ONCOLOGY Q3 CELL BIOLOGY
最新[2023]版:
Q1 DERMATOLOGY Q2 CELL BIOLOGY Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Dermatology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Dermatology, Beijing Tongren Hospital, Capital Medical University, Beijing, China [2]Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China [3]Genetics and Birth Defects Control Center, National Center for Children's Health, Beijing, China [4]MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China [*1]Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China. [*2]Beijing Children’s Hospital, Capital Medical University, Beijing 100045, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)